Sir Christopher Evans may have raised £100 million this year, but he is still worried about the lack of investment in the UK's biotech industry. He spoke to Mark Dunne
Pivotal Laboratories, a Yorkshire-based business that conducts clinical trials for pharmaceutical and biotech firms, has completed a multi-million-pound management buyout with the aid of Northern Venture Managers (NVM).
